The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Gvozdeva A.D.

Chazov National Medical Research Center for Cardiology

Sobolevskaya M.S.

Chazov National Medical Research Center for Cardiology

Sharf T.V.

Chazov National Medical Research Center for Cardiology

Kuznetsova T.V.

Chazov National Medical Research Center for Cardiology

Masenko V.P.

Chazov National Medical Research Center for Cardiology

Ageev F.T.

Chazov National Medical Research Center for Cardiology

Ovchinnikov A.G.

Chazov National Medical Research Center for Cardiology

Influence of sacubitril/valsartan on exercise tolerance, left ventricular mass index and diastolic function in patients with HFpEF and left ventricular hypertrophy

Authors:

Gvozdeva A.D., Sobolevskaya M.S., Sharf T.V., Kuznetsova T.V., Masenko V.P., Ageev F.T., Ovchinnikov A.G.

More about the authors

Journal: Russian Cardiology Bulletin. 2023;18(3): 67‑75

Views: 721

Downloaded: 29


To cite this article:

Gvozdeva AD, Sobolevskaya MS, Sharf TV, Kuznetsova TV, Masenko VP, Ageev FT, Ovchinnikov AG. Influence of sacubitril/valsartan on exercise tolerance, left ventricular mass index and diastolic function in patients with HFpEF and left ventricular hypertrophy. Russian Cardiology Bulletin. 2023;18(3):67‑75. (In Russ.)
https://doi.org/10.17116/Cardiobulletin20231803167

Recommended articles:

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.